Effect of TM208 on QGY-7703 xenograft tumor growth

Anti-Cancer Drugs

Volumn 19, Issue 6, 2008, Pages 593-598

  Zhang, Ning ^a   Guo, Wei ^a   Wang, Li ^a   Huang, Wei ^a   Xu, Bo ^a   Ge, Zemei ^a   Li, Min ^a   Li, Run Tao ^a   Cui, Jing Rong ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Cell cycle arrest; Dithiocarbamate; Extracellular signal regulated kinase 1 2 signal pathway; P38 signal pathway; QGY 7703

Indexed keywords

4 METHYLPIPERAZINE 1 CARBODITHIOIC ACID 3 CYANO 3,3 DIPHENYLPROPYL ESTER; ANTINEOPLASTIC AGENT; CELL CYCLE PROTEIN; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; CYCLOPHOSPHAMIDE; DITHIOCARBAMIC ACID DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE C ALPHA; SULFORHODAMINE B; THREONINE; TM 208; TYROSINE; UNCLASSIFIED DRUG; 4 METHYLPIPERAZINE 1 CARBODITHIOC ACID 3 CYANO 3,3 DIPHENYLPROPYL ESTER HYDROCHLORIDE; 4-METHYLPIPERAZINE-1-CARBODITHIOC ACID 3-CYANO-3,3-DIPHENYLPROPYL ESTER HYDROCHLORIDE; CYCLIN B; PIPERAZINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKOPENIA; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; WEIGHT REDUCTION; WESTERN BLOTTING; ANIMAL; CANCER TRANSPLANTATION; CELL DIVISION; DRUG EFFECT; LIVER TUMOR; PATHOLOGY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CDC2 PROTEIN KINASE; CELL DIVISION; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN B; G2 PHASE; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MAP KINASE SIGNALING SYSTEM; MICE; NEOPLASM TRANSPLANTATION; PIPERAZINES; TRANSPLANTATION, HETEROLOGOUS;

EID: 53749083682     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e328301390d     Document Type: Article

References (32)

1. Suzui M, Masuda M, Lim J, Albanese C, Pestell RG, Weinstein IB. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21CIP1 and inhibition of expression of cyclin D1. Cancer Res 2002; 62:3997-4006.
2. Len C, Boulognemerlot AS, Postel D. Synthesis and antifungal activity of novel bis(dithiocarbamate) derivatives of glycerol. J Agric Food Chem 1996; 44:2856-2858.
3. Cascio G, Lorenzi L, Caglio D, Manghisi E, Arcamone F, Guanti G, et al.Synthesis and antibacterial activity of C-4 thio-and dithiocarbamate monobactam derivatives. Farmaco 1996; 51:189-196.
4. Lai CS. Preparation of conjugates of dithiocarbamates with drugs. P. PCT Int. Appl, WO 9855453 A1, 1998-12-10(66).
5. Hidaka S, Funakoshi T, Shimada H, Tsuruoka M, Kojima S. Comparative effects of diethyldithiocarbamate and N-benzyl-D-glucamine dithiocarbamate on cis-diamminedichloroplatinum-induced toxicity in kidney and gastrointestinal tract in rats. J Appli Toxicol 1995; 15:267-273.
6. Guo BG, Ge ZM, Cheng TM. Synthesis and anti-tumor activity of 1,4-bis [3-(aminodithiocarboxyl) propionyl] pipera-zine derivatives. Acta Pharm Sinica 2001; 36:185-187.
7. Ge ZM, Li RT, Cheng TM, Cui JR. Synthesis and biological activities of dipiperazinium salts containing dithiocarboxyl. Arch Pharm Pharm Med Chem 2001; 334:173-176.
8. Li RT, Cheng TM, Cui JR. Study on the synthesis and anticancer activity of dithiocarbamate. P.US Pat:1328999,2002-01.
9. Li RT, Cheng TM, Cui JR. Piperazine mono(dithio)-carbamate ester compounds and analog: preparation method and pharmaceutical use. P. US Pat: 10/157733,2002-05; WO Apply No: PCT/US02/16772, 2002-5.
10. Guo W, Rang FX, Wang RQ, Cui JR, Li RT, Cheng TM, et al.Antitumor effect of hydrochloride 4-methyl-piperazine-1-carbodithioc acid 3-cyano-3, 3-diphenyl-propyl ester. Chin J Clin Pharmacol Ther 2004; 9:59-62.
11. Wang JB. Establishment and some characteristics of a hepatoma cell line (QGY-7703). Chung-Hua Chung Liu Tsa Chih 1981; 3:241-244.
12. Liu X, Yan S, Zhou T, Terada Y, Erikson RL. The MAP kinase pathway is required for entry into mitosis and cell survival. Oncogene 2004; 23:763-776.
13. Jiang XM, Kong DT, Han FB, Ling XM, Li RT, Cui JR, et al.Studies on the metabolism of 4-methylpiperazine-1-carbodithioc acid 3-cyano-3, 3-diphenylpropyl ester hydrochloride in rat bile by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom 2007; 21:1599-1605.
14. Katz M, Amit I, Yarden Y. Regulation of MAPKs by growth factors and receptor tyrosine kinases. Biochimica et Biophysica Acta 2007; 1773:1161-1176.
15. Shaul YD, Seger R. The MEK/ERK cascade: from signaling specificity to diverse functions. Biochimica et Biophysica Acta 2007; 1773:1213-1226.
16. Motomura W, Tanno S, Takahashi N, Nagamine M, Fukuda M, Kohgo Y. Involvement of MEK-ERK signaling pathway in the inhibition of cell growth by troglitazone in human pancreatic cancer cells. Biochem Biophys Res Commun 2005; 332:89-94.
17. Wu FS, Zheng SS, Wu LJ, Teng LS, Ma ZM, Zhao WH. Calcitriol inhibits the growth of MHCC97 heptocellular cell lines by down-modulating c-met and ERK expressions. Liver Int 2007; 27:700-707.
18. Liu JF, Crepin M, Liu JM, Barritault D, Ledoux D. FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. Biochem Biophys Res Commun 2002; 293:1174-1182.
19. Katagiri K, Hattori S, Nakamura S, Yamamoto T, Yoshida T, Katagiri T. Activation of Ras and formation of GAP complex during TPA-induced monocytic di.erentiation of HL-60 cells. Blood 1994; 84:1780-1789.
20. Thomas SM, DeMarco M, D'Arcangelo G, Halegoua S, Brugge JS. Ras is essential for nerve growth factor- and phorbol ester-induced tyrosine phosphorylation of MAP kinases. Cell 1992; 68:1031-1040.
21. Alexandropoulos K, Qureshi SA, Foster DA. Ha-Ras functions downstream from protein kinase C inv-Fps-induced gene expression mediated by TPA response elements. Oncogene 1993; 8:803-807.
22. Hess A, Wijayanti N, Neuschafer-Rube AP, Katz N, Kietzmann T, Immenschuh S. Phorbol ester-dependent activation of peroxiredoxin I gene expression via a protein kinase C, Ras, p38 mitogen-activated protein kinase signaling pathway. J Biol Chem 2003; 278:45419-45434.
23. Ueda Y, Hirai S, Osada S, Suzuki A, Mizuno K, Ohno S. Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J Biol Chem 1996; 271:23512-23519.
24. Soderholm H, Olsson A, Lavenius E, Ronnstrand L, Nanberg E. Activation of Ras, Raf-1 and protein kinase C in di.erentiating human neuroblastoma cells after treatment with phorbol ester and NGF. Cell Signal 2001; 13: 95-104.
25. Tobin D, Nilsson M, Toftgard R., Ras-independent activation of Rel-family transcription factors by UVB and TPA in cultured keratinocytes. Oncogene 1996; 12:785-793.
26. Barnard D, Diaz B, Clawson D, Marshall M. Oncogenes, growth factors and phorbol esters regulate Raf-1 through common mechanisms. Oncogene 1998; 17:1539-1547.
27. Navas TA, Nguyen AN, Hideshima T, Reddy M, Ma JY, Haghnazari E, et al.Inhibition of p38 MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-XL, Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo. Leukemia 2006; 20:1017-1027.
28. Vermeulen K, Van Bockstaele DR, Berneman ZN. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 2003; 36:131-149.
29. Coleman TR, Dunphy WG. Cdc2 regulatory factors. Curr Opin Cell Biol 1994; 6:877-882.
30. Galaktionov K, Jessus C, Beach D. Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation. Genes Dev 1995; 9:1046-1058.
31. 1 phase cell cycle machinery. Bioessays 2000; 22:818-826.
32. McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EWT, Chang F. Roles of the Raf/MEK/ERK pathway in cell growth, malignant, transformation and drug resistance. Biochimica et Biophysica Acta 2007; 1773:1263- 1284.